DE2005117A1 - Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease Virus - Google Patents
Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease VirusInfo
- Publication number
- DE2005117A1 DE2005117A1 DE19702005117 DE2005117A DE2005117A1 DE 2005117 A1 DE2005117 A1 DE 2005117A1 DE 19702005117 DE19702005117 DE 19702005117 DE 2005117 A DE2005117 A DE 2005117A DE 2005117 A1 DE2005117 A1 DE 2005117A1
- Authority
- DE
- Germany
- Prior art keywords
- solutions
- disease virus
- enrichment
- purification
- newcastle disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000746 purification Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 title description 9
- 241000711404 Avian avulavirus 1 Species 0.000 title description 8
- 241000700605 Viruses Species 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 17
- 210000002257 embryonic structure Anatomy 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- KNIUHBNRWZGIQQ-UHFFFAOYSA-N 7-diethoxyphosphinothioyloxy-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 KNIUHBNRWZGIQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702005117 DE2005117A1 (de) | 1970-02-05 | 1970-02-05 | Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease Virus |
| NL7101370A NL7101370A (enrdf_load_stackoverflow) | 1970-02-05 | 1971-02-02 | |
| BE762581A BE762581A (fr) | 1970-02-05 | 1971-02-05 | Procede de concentration et de purification de solutions du virus de lamaladie de newcastle |
| ZA710732A ZA71732B (en) | 1970-02-05 | 1971-02-05 | Process for the enrichment and purification of solutions of the newcastle disease virus |
| FR7103915A FR2078246A5 (enrdf_load_stackoverflow) | 1970-02-05 | 1971-02-05 | |
| GB1295814D GB1295814A (enrdf_load_stackoverflow) | 1970-02-05 | 1971-04-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702005117 DE2005117A1 (de) | 1970-02-05 | 1970-02-05 | Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease Virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2005117A1 true DE2005117A1 (de) | 1971-08-19 |
Family
ID=5761435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702005117 Pending DE2005117A1 (de) | 1970-02-05 | 1970-02-05 | Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease Virus |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE762581A (enrdf_load_stackoverflow) |
| DE (1) | DE2005117A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2078246A5 (enrdf_load_stackoverflow) |
| GB (1) | GB1295814A (enrdf_load_stackoverflow) |
| NL (1) | NL7101370A (enrdf_load_stackoverflow) |
| ZA (1) | ZA71732B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7216091A (enrdf_load_stackoverflow) * | 1971-12-03 | 1973-06-05 |
-
1970
- 1970-02-05 DE DE19702005117 patent/DE2005117A1/de active Pending
-
1971
- 1971-02-02 NL NL7101370A patent/NL7101370A/xx unknown
- 1971-02-05 FR FR7103915A patent/FR2078246A5/fr not_active Expired
- 1971-02-05 BE BE762581A patent/BE762581A/xx unknown
- 1971-02-05 ZA ZA710732A patent/ZA71732B/xx unknown
- 1971-04-19 GB GB1295814D patent/GB1295814A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE762581A (fr) | 1971-08-05 |
| FR2078246A5 (enrdf_load_stackoverflow) | 1971-11-05 |
| NL7101370A (enrdf_load_stackoverflow) | 1971-08-09 |
| ZA71732B (en) | 1971-10-27 |
| GB1295814A (enrdf_load_stackoverflow) | 1972-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3712767A1 (de) | Immunologisches adjuvans | |
| DE3785754D1 (de) | Modifizierung von alginaten oder sonstigen uronsaeureverbindungen durch co2-behandlung. | |
| Day et al. | Plant carbonic anhydrase | |
| DE2355094C3 (de) | Verfahren zur Herstellung eines Tetanus-Impfstoffs | |
| DE2005117A1 (de) | Verfahren zur Anreicherung und Reim gung von Losungen des Newcastle Disease Virus | |
| DD300833A7 (de) | Verfahren zur herstellung von inaktivierten influenza-vollvirusimpfstoffen | |
| Sutherland | THE SYDNEY FUNNEL–WEB SPIDER (ATRAX ROBUSTUS) 2. FRACTIONATION OF THE FEMALE VENOM INTO FIVE DISTINCT COMPONENTS | |
| DE2508396A1 (de) | Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel | |
| Reagan et al. | Effect of zika virus and bwamba virus in the cave bat (Myotus lucifugus) | |
| DE2213709A1 (de) | Verfahren zur Herstellung eines Interferonerzeugers | |
| DE1953812A1 (de) | Verfahren zur Konzentrierung und Reinigung von Schweinepest-Virusloesungen | |
| DE3005495C2 (de) | Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen | |
| KOCAN et al. | Freeze‐Preservation of Leucocytozoon simondi Sporozoites in Liquid Nitrogen | |
| DE1935291A1 (de) | Verfahren zur Reinigung von Maul- und Klauenseuche-Virusloesungen | |
| DE1168015B (de) | Verfahren zur Reinigung von Virusantigen | |
| CH650682A5 (de) | Verfahren zur herstellung von reinem hepatitis b antigen aus menschlichem plasma. | |
| Barlow et al. | Ethylene oxide for sterilizing diets | |
| DE2265620C2 (de) | Mittel zur passiven Immunisierung gegen die toxischen Effekte von Infektionen durch Elastase bildende Bakterien und Verfahren zur Herstellung desselben | |
| DE1941709C3 (de) | Verfahren zur enzymatischen Vermehrung von informatorischer Ribonucleinsäure | |
| Oliver-González | Histopathological and immunological observations after inoculation of substances isolated from the muscle and cuticle of Ascaris lumbricoides | |
| Williams | Homocytotropic antibody to Coenurus cerebralis antigen in sheep | |
| DE2510987C2 (de) | Verfahren zur Herstellung eines Tetanusimpfstoffes | |
| DE2220053C3 (de) | Mittel zur aktiven und passiven Immunisierung gegen die toxischen Effekte von Infektionen durch Elastase bildende Bakterien und Verfahren zur Herstellung derselben | |
| Innes et al. | Occult Endemic Encephalitozoönosis of the Central Nervous System of Mice | |
| DE2644149A1 (de) | Neue parasiten-antigene |